Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPMY | ZTS | TAK | NBIX | UTHR |
| Company | Astellas Pharma Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 9.5600 | 173.59 | 13.27 | 142.30 | 274.26 |
| High | 9.6697 | 174.71 | 13.33 | 143.05 | 275.42 |
| Low | 9.5600 | 172.19 | 13.26 | 139.77 | 272.29 |
| Last | 9.6400 | 174.39 | 13.28 | 141.65 | 274.67 |
| Change | +0.1600 | +0.33 | +0.06 | -0.64 | +0.41 |
| % Change | +1.69% | +0.19% | +0.45% | -0.45% | +0.15% |
| Volume | 181,700 | 2,254,400 | 594,400 | 500,600 | 333,200 |
| 20-Day Average Volume | 307,065 | 3,316,225 | 1,418,570 | 778,035 | 553,425 |
| Previous Close | 9.4800 | 174.06 | 13.22 | 142.29 | 274.26 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.7280 | 164.63 | 13.24 | 139.78 | 256.78 |
| 20-Day Raw Stochastic | 29.79% | 97.99% | 70.83% | 65.77% | 98.22% |
| 20-Day Relative Strength | 41.70% | 59.23% | 45.79% | 54.64% | 69.48% |
| Weighted Alpha | -41.31 | +2.61 | -17.58 | +50.96 | +36.59 |
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 100% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 05/13/24 | +3.86% since 05/13/24 | +1.30% since 05/13/24 | +4.04% since 05/13/24 | +3.91% since 05/13/24 |
| Low | 9.4200 on 05/16/24 | 168.63 on 05/14/24 | 13.21 on 05/17/24 | 134.79 on 05/14/24 | 264.35 on 05/14/24 |
| High | 9.9700 on 05/14/24 | 174.99 on 05/15/24 | 13.49 on 05/14/24 | 143.05 on 05/20/24 | 275.42 on 05/20/24 |
| 1-Month | |||||
| %Chg | +1.47% since 04/19/24 | +19.04% since 04/19/24 | +0.30% since 04/19/24 | +7.31% since 04/19/24 | +15.44% since 04/19/24 |
| Low | 9.3600 on 04/24/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 131.79 on 04/22/24 | 233.27 on 04/24/24 |
| High | 10.3000 on 05/03/24 | 174.99 on 05/15/24 | 13.49 on 05/14/24 | 145.22 on 05/01/24 | 275.42 on 05/20/24 |
| 3-Month | |||||
| %Chg | -13.46% since 02/20/24 | -6.52% since 02/20/24 | -10.39% since 02/20/24 | +6.78% since 02/20/24 | +28.25% since 02/20/24 |
| Low | 9.1500 on 04/16/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 129.15 on 03/01/24 | 214.52 on 02/21/24 |
| High | 11.3200 on 03/22/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 275.42 on 05/20/24 |
| 6-Month | |||||
| %Chg | -21.50% since 11/20/23 | -0.95% since 11/20/23 | -5.21% since 11/20/23 | +29.44% since 11/20/23 | +19.95% since 11/20/23 |
| Low | 9.1500 on 04/16/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 108.63 on 11/21/23 | 208.62 on 02/08/24 |
| High | 12.7099 on 01/08/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 275.42 on 05/20/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,155,604 | 79,422,712 | 41,839,144 | 14,319,639 | 12,165,075 |
| Shares Outstanding, K | 1,809,663 | 456,295 | 3,164,837 | 100,637 | 44,356 |
| Annual Sales | 11,108,100,000 | 8,544,000,000 | 29,419,960,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | 118,070,000 | 2,344,000,000 | 994,060,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 2,793,590,000 | 2,190,000,000 | 5,397,000,000 | 515,300,000 | 677,700,000 |
| Last Quarter Net Income | -224,230,000 | 599,000,000 | -91,000,000 | 43,400,000 | 306,600,000 |
| 60-Month Beta | 0.37 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 04/25/24 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 0.42 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | 0.168 on 09/27/23 | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | 09/27/23 | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 27.66 | 32.23 | 8.53 | 39.09 | 12.87 |